Document is current
Any future updates will be listed below
-
Authors
Ye, Linlei https://orcid.org/0000-0002-2885-6404
Wong, Tiffany
Lavine, Elana
Cook, Victoria E.
Erdle, Stephanie C.
- License Information
-
More Information
Article History
Received: 28 April 2023
Accepted: 15 September 2023
First Online: 6 October 2023
Declarations
:
: This retrospective case series was completed as part of a quality improvement initiative. Under article 2.5 of the Tri Council Policy Statement, quality improvement initiatives are not subject to institutional ethical review.
: Not applicable.
: LY has no conflicts to declare.TW has been a member of advisory boards for Leo Pharma, Bausch Health and Aralez and has received honoraria from ALK, Pfizer, Sanofi, Stallergenes Greer, Cera Ve and Polaris Health.EL has been a member of advisory boards for Medexus, Miravo, Aralez, Stallergenes and ALK, and has a current consulting role with ALK.VEC has been a member of advisory boards for Sanofi Genzyme, Bausch Health, and ALK, and has received honoraria from Aralez Pharmaceuticals, ALK, Pfizer, and CSL Behring.SCE has been a member on advisory boards for ALK, has received honoraria from La Roche Posay, and has received a research grant from Avir-Pharma, and an educational grant from Pfizer.
